Genetic and epigenetic variations in iPSCs: potential causes and implications for application
about
A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future ProspectsPharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?Pluripotent Stem Cells: Current Understanding and Future DirectionsValue of Organoids from Comparative Epithelia ModelsSetting Up a Haplobank: Issues and SolutionsHuman pluripotent stem cell culture: considerations for maintenance, expansion, and therapeuticsDifferential response of epiblast stem cells to Nodal and Activin signalling: a paradigm of early endoderm development in the embryoOptimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cellsChoices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming StrategiesLong-term culture of genome-stable bipotent stem cells from adult human liverAutomated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cellsGenetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouseToward pluripotency by reprogramming: mechanisms and applicationImproved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickaseSolving the puzzle of Parkinson's disease using induced pluripotent stem cells.Large-scale mapping of mammalian transcriptomes identifies conserved genes associated with different cell states.Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and DisadvantagesH1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem CellsCRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Deciphering the heterogeneity in DNA methylation patterns during stem cell differentiation and reprogramming.Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin.Aged iPSCs display an uncommon mitochondrial appearance and fail to undergo in vitro neurogenesis.Naïve-like conversion enhances the difference in innate in vitro differentiation capacity between rabbit ES cells and iPS cells.Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus.A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.Human induced hepatic lineage-oriented stem cells: autonomous specification of human iPS cells toward hepatocyte-like cells without any exogenous differentiation factors.Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling.Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field.Advances in reprogramming-based study of neurologic disordersGeneration of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed CellsUsing Stem Cells to Model Diseases of the Outer RetinaCytoskeletal Expression and Remodeling in Pluripotent Stem Cells.Human iPSC derived disease model of MERTK-associated retinitis pigmentosaAsymmetric Regulation of Peripheral Genes by Two Transcriptional Regulatory NetworksAnalysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity.Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point MutationCtIP-Specific Roles during Cell Reprogramming Have Long-Term Consequences in the Survival and Fitness of Induced Pluripotent Stem CellsThe p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters
P2860
Q26746033-761600AE-F59B-4FE8-862B-7B66B00BA21EQ26765883-F3075A3E-4674-4289-9F48-231A55A63BC5Q26769981-B2F8EE75-8054-4061-BADA-0F28E4271465Q26775816-17544204-4D28-47A7-A16B-E6D06263F0A9Q26801583-4A108953-492B-48F2-9686-FC4EF255C691Q26825384-E45A8B53-D9C7-4380-829F-5E21FA58CE0FQ26995657-11D901F8-EE68-40DA-B4B2-13B5922B46A1Q27015774-D253E623-A6B7-47C2-8E11-2D4A2E329F44Q28085565-05E5B484-6B2D-4A45-A6E9-7E2522A2A794Q28254408-3E5E7824-FB0C-4851-BB68-4242405ECDD7Q28265816-11159ECD-12CD-4D13-A5C8-6A08299B48A8Q28544903-C6F62F52-C11F-47EF-A777-749D8AA8966CQ28833688-24A5EB3E-8D9C-42D9-ACE4-F6794888BD9FQ29114083-A05DB540-7075-405B-BCA8-5C6C6CC74513Q33358637-FE8CEAC2-4609-487C-A14D-BCAB56E7F2E2Q33557481-CE37B685-C279-4902-8DD6-2FD538B7A66FQ33615105-1D8BD110-71A0-43F9-837B-A564BCF0AFB6Q34046907-FEC78135-3BF4-449A-B368-3AB71F811255Q34047602-A08B75FF-FC2F-4CDD-B3C0-FADB6A28A8C9Q34468304-57AC939B-57EC-4CBD-A00E-A46A47AD3E1CQ34565777-2E354617-5996-4770-ABCF-510BB540CC10Q34797997-0C3D59AB-DC63-4A69-B853-80BE98E0AB7CQ34982517-D41FF971-40A1-4550-B63B-3F59CF6BC197Q35161004-96285DC4-A470-4309-BF28-8642474378D4Q35183911-BDF0BD64-F929-448B-96F9-26B076656A2DQ35200170-B23707A0-8BB2-4DFB-B0D5-8FDC1316CA32Q35393151-51A629D1-C321-401B-B7E1-4381A52BB48BQ35532165-7BCB15FE-4A5B-4A97-8DC8-858692280971Q35583101-AF38D0AB-4E30-4816-9FDD-89C32B3CE26CQ35623887-3ED84AC3-4E70-459B-B7E2-E45057FE7FBBQ35635245-63543705-E2DE-483B-B834-689F04EB8497Q35747887-35CB64CD-DB86-4841-8707-F776A2BB51D2Q35768469-7A180922-CDB4-4EEE-9721-036B0382CFA9Q35895005-F91F9A0E-1817-4B25-B643-0A821C038FD8Q35937882-3B77665F-7621-4BE9-B19A-A290D17F2E5DQ36092444-A54D30D7-5B1A-4873-8752-FDE1692B8337Q36233059-6C62E59F-AE24-470C-9D27-0830F186130DQ36236565-3B884FD8-20AA-4C2C-B487-17EF9226C6CCQ36243930-433E59E7-439E-4945-B981-DAC64934E8F7Q36293410-5F020619-84C5-4076-A865-46F09E7117B6
P2860
Genetic and epigenetic variations in iPSCs: potential causes and implications for application
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic and epigenetic variati ...... d implications for application
@en
Genetic and epigenetic variati ...... implications for application.
@nl
type
label
Genetic and epigenetic variati ...... d implications for application
@en
Genetic and epigenetic variati ...... implications for application.
@nl
prefLabel
Genetic and epigenetic variati ...... d implications for application
@en
Genetic and epigenetic variati ...... implications for application.
@nl
P2860
P1433
P1476
Genetic and epigenetic variati ...... d implications for application
@en
P2093
Gaoyang Liang
P2860
P304
P356
10.1016/J.STEM.2013.07.001
P407
P577
2013-08-01T00:00:00Z